Orchestra BioMed Holdings, Inc.
OBIO
$2.60
$0.051.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.94M | 2.89M | 2.64M | 2.65M | 2.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.94M | 2.89M | 2.64M | 2.65M | 2.08M |
| Cost of Revenue | 216.00K | 214.00K | 204.00K | 193.00K | 166.00K |
| Gross Profit | 2.73M | 2.67M | 2.43M | 2.45M | 1.91M |
| SG&A Expenses | 24.09M | 24.30M | 23.93M | 22.22M | 22.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 74.21M | 71.69M | 66.94M | 62.75M | 60.37M |
| Operating Income | -71.27M | -68.80M | -64.30M | -60.11M | -58.29M |
| Income Before Tax | -69.70M | -66.32M | -61.02M | -57.69M | -55.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -69.70 | -66.32 | -61.02 | -57.69 | -55.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -69.70M | -66.32M | -61.02M | -57.69M | -55.58M |
| EBIT | -71.27M | -68.80M | -64.30M | -60.11M | -58.29M |
| EBITDA | -70.94M | -68.48M | -63.99M | -59.81M | -58.00M |
| EPS Basic | -1.83 | -1.77 | -1.66 | -1.60 | -1.57 |
| Normalized Basic EPS | -1.14 | -1.11 | -1.03 | -0.97 | -0.96 |
| EPS Diluted | -1.83 | -1.77 | -1.66 | -1.60 | -1.57 |
| Normalized Diluted EPS | -1.14 | -1.11 | -1.03 | -0.97 | -0.96 |
| Average Basic Shares Outstanding | 152.31M | 149.72M | 147.26M | 144.34M | 141.96M |
| Average Diluted Shares Outstanding | 152.31M | 149.72M | 147.26M | 144.34M | 141.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |